H. Irene Su
H. Irene Su , M.D., MSCE
Stanford University, Stanford, CA. BS, Biological Sciences; AB, East Asian Studies, 1997.
Albert Einstein College of Medicine, Bronx, NY. MD, 2001.
University of Pennsylvania, Philadelphia, PA. MSCE, Master’s of Science in Clinical Epidemiology, 2008.
Residency in Obstetrics and Gynecology, University of Pennsylvania, 2001-2005.
Fellowship in Reproductive Endocrinology and Infertility, University of Pennsylvania, 2005-2008.
Instructor, Division of Reproductive Endocrinology and Infertility, University of Pennsylvania, 2008-2009.
Assistant Professor of Reproductive medicine, Division of Reproductive Endocrinology and Infertility, University of California, San Diego, 2009-2015.
Associate Professor of Reproductive Medicine, Division of Reproductive Endocrinology and Infertility, University of California, San Diego, 2015 - present.
Board certified in Obstetrics and Gynecology, 2007.
Board certified in Reproductive Endocrinology and Infertility, 2010.
Honors and Awards
Alpha Omega Alpha Honor Medical Society
American Medical Women’s Association Janet M. Glasgow Achievement Citation
Resident Teaching Award for Excellence in Medical Student Education, Obstetrics and Gynecology, University of Pennsylvania
Resident Research Award, Obstetrics and Gynecology, University of Pennsylvania
American Society of Reproductive Medicine In-Training Award for Research
American Society of Reproductive Medicine Prize Paper Award
Reproductive epidemiology, oncofertility, ovarian aging, cancer survivorship
Current Research Focus
Our group of physicians and researchers is dedicated in improving reproductive health after cancer diagnosis and treatment. In the U.S., there are more than 500,000 reproductive-aged women who have survived cancer. Cancer treatments can deplete the finite number of oocytes in each woman, incurring risks of infertility and premature ovarian aging that significantly impair quality of life after cancer. Reproductive health after cancer is a new field that is clinically important to young cancer survivors, but vastly understudied. We are focused on three primary research areas: 1) measuring ovarian function, 2) developing research tools to study this population, and 3) generating and testing health communication and education interventions on reproductive health issues after cancer.
Complete List of Published Work in Mybibliography
Dominick SA, McLean MR, Whitcomb BW, Gorman JR, Mersereau JE, Bouknight JM, Su HI . “Contraceptive Practices Among Female Cancer Survivors of Reproductive Age.” Obstetrics and Gynecology (2015); 126(3):498-507. PMCID: PMC4545298.
Gorman JR, Su HI , Roberts SC, Dominick SA, Malcarne VL. “Experiencing reproductive concerns as a female cancer survivor is associated with depression.” Cancer (2015): 121(6): 935-42. PMID: 4352116.
Su HI , Haunschild CH, Chung K, Komrokian S, Boles S, Sammel MD, DeMichele A. “Pre-chemotherapy anti-mullerian hormone, age and body size predict timing of return of ovarian function in young breast cancer patients.” Cancer (2014); 120(23): 3691-8. PMCID: PMC4239183.
Su HI , Sammel MD, Homer MV, Bui K, Haunschild C, Stanczyk F. “Comparability of AMH levels among commercially available immunoassays.” Fertility and Sterility (2014); 101 (6): 1766-72. PMID: 24726216.
Dominick SA, Whitcomb BW, Gorman JR, Mersereau JE, Chung K, Su HI . “Factors associated with pregnancy attempts among female young adult cancer survivors.” Journal of Cancer Survivorship (2014): 8(4): 571-9. PMCID: PMC4221647.
Su HI , Maas K, Sluss P, Chang RJ, Hall JE, Joffe H. “The impact of depot GnRH agonist on AMH levels in healthy reproductive-aged women.” Journal of Clinical Endocrinology and Metabolism (2013); 98(12): E1961-6. PMCID: PMC3849679.
Gorman JR, Su HI , Pierce JP, Roberts SC, Dominick SA, Malcarne VL. “A multidimensional scale to measure the reproductive concerns of young adult female cancer survivors.” Journal of Cancer Survivorship (2013): 8(2): 218-28. PMID: 24352870.
Su HI , Flatt SW, Natarajan L, DeMichele A, Steiner AZ. “Impact of breast cancer on anti-Mullerian hormone levels in young women.” Breast Cancer Research and Treatment (2013); 137 (2): 571-7. PMC3540167.
Su HI , Chung K, Sammel MD, Gracia CR, DeMichele A. “Antral follicle count provides additive information to hormone measures for determining ovarian function in breast cancer survivors.” Fertility and Sterility (2011): 95 (5): 1857-9. PMCID: PMC3062716.
Su HI , Sammel MD, Green JA, Velders L, Stankiewicz C, Matro J, Freeman EW, Gracia CR, DeMichele AD. “Anti-mullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive-aged breast cancer survivors.” Cancer (2010) 116(3): 592-9 PMCID: PMC 2815049.